Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics
- PMID: 12587665
- DOI: 10.1023/a:1021648128758
Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics
Abstract
Association of alleles at the Taq1 A, Taq1 B, intron 6, Taq1 D, exon 7, exon 8, and promoter-141C sites of the D2 dopamine receptor gene with D2 dopamine receptor binding characteristics in the caudate nucleus of Caucasian alcoholic and nonalcoholic subjects was determined. For the Taq1 D, exon 7, exon 8, and promoter- 141C sites there were no significant allelic differences in Bmax (number of binding sites) or Kd (binding affinity) of the D2 dopamine receptors. However, subjects having the minor alleles at the Taq1 A, Taq1 B, and intron 6 sites had significantly lower Bmax than subjects not having them. None of these three polymorphisms had any significant effect on Kd. Highly significant linkage disequilibria were observed among the Taq1 A, Taq1 B, and intron 6 polymorphic sites, but linkage disequilibria between these three sites and each of the Taq1 D, exon 7, exon 8, and promoter-141C sites were of lesser or of no significance. Taken together, these findings suggest that the Taq1 A, Taq1 B, and intron 6 polymorphisms, but not the Taq1 D, exon 7, exon 8, and promoter-141C polymorphisms, are in linkage disequilibrium with a functional allelic variant that affects D2 dopamine receptor expression.
Similar articles
-
D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene.Mol Psychiatry. 1998 May;3(3):261-5. doi: 10.1038/sj.mp.4000343. Mol Psychiatry. 1998. PMID: 9672902
-
Haplotypes at the DRD2 locus and severe alcoholism.Am J Med Genet. 2000 Oct 9;96(5):622-31. doi: 10.1002/1096-8628(20001009)96:5<622::aid-ajmg7>3.0.co;2-5. Am J Med Genet. 2000. PMID: 11054769
-
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.Pharmacogenetics. 1997 Dec;7(6):479-84. doi: 10.1097/00008571-199712000-00006. Pharmacogenetics. 1997. PMID: 9429233
-
Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients.Prog Neuropsychopharmacol Biol Psychiatry. 2000 Oct;24(7):1105-13. doi: 10.1016/s0278-5846(00)00132-9. Prog Neuropsychopharmacol Biol Psychiatry. 2000. PMID: 11131175
-
The dopamine D2 receptor 5'-flanking variant, -141C Ins/Del, is not associated with reduced dopamine D2 receptor density in vivo.Pharmacogenetics. 1999 Aug;9(4):505-9. Pharmacogenetics. 1999. PMID: 10780270
Cited by
-
Polymorphisms of Dopamine Receptor Genes and Parkinson's Disease: Clinical Relevance and Future Perspectives.Int J Mol Sci. 2021 Apr 6;22(7):3781. doi: 10.3390/ijms22073781. Int J Mol Sci. 2021. PMID: 33917417 Free PMC article. Review.
-
Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset.Neurogenetics. 2013 Nov;14(3-4):173-9. doi: 10.1007/s10048-013-0364-y. Epub 2013 May 4. Neurogenetics. 2013. PMID: 23644918 Free PMC article.
-
Dopaminergic Control of the Feeding Circuit.Endocrinol Metab (Seoul). 2021 Apr;36(2):229-239. doi: 10.3803/EnM.2021.979. Epub 2021 Apr 6. Endocrinol Metab (Seoul). 2021. PMID: 33820393 Free PMC article. Review.
-
Genetic influences on outcome following traumatic brain injury.Neurochem Res. 2007 Apr-May;32(4-5):905-15. doi: 10.1007/s11064-006-9251-3. Epub 2007 Mar 7. Neurochem Res. 2007. PMID: 17342413 Review.
-
Evaluation of association of DRD2 TaqIA and -141C InsDel polymorphisms with food intake and anthropometric data in children at the first stages of development.Genet Mol Biol. 2018 Jul/Sept.;41(3):562-569. doi: 10.1590/1678-4685-GMB-2017-0202. Epub 2018 Jul 23. Genet Mol Biol. 2018. PMID: 30044466 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources